ZEAL (Zealand Pharma A/S ADR) stock is currently covered by 2 analysts. The average analyst rating isĀ 3.5 out of 5.

ZEAL analysts have given it a high price target of $42, mean price target of $38.75, and a low price target of $35.5.

ZEAL currently has an estimated 12-Month price forecast of $38.75 based on the average analyst price target.

[wpdatatable id=10 var1=ZEAL]

Leave a Reply

Your email address will not be published. Required fields are marked *